Tonsil Cancer
8
4
4
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Treatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy
ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx
Surgeon-performed Outpatient Transoral and Transcervical Ultrasound of the Oropharynx
Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Outpatient Ultrasound for the Diagnostic Work-up of Oropharynx Cancer
Photon Therapy Versus Proton Therapy in Early Tonsil Cancer.
New Modalities for Detection of Oropharyngeal Cancer